Imodium a-d and Alendronate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium a-d (loperamide hydrochloride) and Alendronate sodium (alendronate sodium). Common drug interactions include nausea among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium a-d and Alendronate sodium. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium a-d?

Imodium a-d has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 8,944 Imodium a-d users. Check the latest studies of Imodium a-d.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

39 people who take Imodium a-d and Alendronate sodium together, and have interactions are studied.

Imodium a-d and Alendronate sodium drug interactions.

What are the common drug interactions of Imodium A-D and Alendronate Sodium, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Decreased appetite
  3. Dehydration (dryness resulting from the removal of water)
  4. Chest pain
  5. Constipation
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Bladder disorder
  8. Blood glucose decreased
  9. Dizziness
  10. Fall

male:

  1. Abdominal pain
  2. Blood creatinine increased
  3. Influenza
  4. International normalised ratio increased
  5. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Red blood cell count decreased
  8. Renal disorder (kidney disease)

What are the common drug interactions of Imodium A-D and Alendronate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Skin infection
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Spinal stenosis (narrowing of spinal column)
  4. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  5. Tenderness (pain or discomfort when an affected area is touched)
  6. Urinary tract infection
  7. Wound infection
  8. Abdominal distension
  9. Abdominal pain lower
  10. Aphasia (damage to the parts of the brain that control language)

60+:

  1. Fatigue (feeling of tiredness)
  2. Chest pain
  3. Blood glucose decreased
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Constipation
  6. Deafness
  7. Dehydration (dryness resulting from the removal of water)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Dizziness
  10. Ear pain

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 33.33%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 15.38%
  3. Multiple Myeloma (cancer of the plasma cells): 6 people, 15.38%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 12.82%
  5. Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 10.26%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 7.69%
  7. Breast Cancer Female: 3 people, 7.69%
  8. Nausea (feeling of having an urge to vomit): 2 people, 5.13%
  9. Migraine (headache): 2 people, 5.13%
  10. Meniere's Disease (a disorder of the inner ear that can affect hearing and balance to a varying degree): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium a-d and Alendronate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium a-d and Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium a-d:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium a-d and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alendronate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and alendronate sodium (the active ingredients of Imodium a-d and Alendronate sodium, respectively), and Imodium a-d and Alendronate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: